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Abstract
Ibuprofen is a widely used non-steroidal anti-inflammatory drug, which has recently been 
associated with increased cardiovascular risk, but its electrophysiological effects have not yet 
been properly studied in isolated cardiac preparations. We studied the effects of ibuprofen on 
action potential characteristics and several transmembrane ionic currents using the 
conventional microelectrode technique and the whole-cell configuration of the patch-clamp 
technique on cardiac preparations and enzymatically isolated ventricular myocytes. In dog 
(200 µM; n=6) and rabbit (100 µM; n=7) papillary muscles, ibuprofen moderately but 
significantly prolonged repolarization at 1 Hz stimulation frequency. In dog Purkinje fibers, 
repolarization was abbreviated, and maximal rate of depolarization was depressed in a 
frequency-dependent manner. Levofloxacin (40 µM) alone did not alter repolarization, but 
augmented the ibuprofen-evoked repolarization lengthening in rabbit preparations (n=7). In 
dog myocytes, ibuprofen (250 µM) did not significantly influence IK1, but decreased the 
amplitude of Ito and IKr potassium currents by 28.2% (60 mV) and 15.2% (20 mV) 
respectively. Ibuprofen also depressed INaL and ICa currents by 19.9% and 16.4%. We 
conclude that ibuprofen seems to be free from effects on AP parameters at lower 
concentrations. However, at higher concentrations it may alter repolarization reserve, 
contributing to the observed proarrhythmic risk in patients.
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List of abbreviations
APA: Action potential amplitude
APD50: Action potential duration at 50% of repolarization
APD90: Action potential duration at 90% of repolarization
ICa: Voltage-dependent calcium current
IK1: Inward rectifier potassium current
IKr: Rapidly activating delayed rectifier potassium current
IKs: Slowly activating delayed rectifier potassium current
INaL: Late sodium current
Ito: Transient outward potassium current
RMP: Resting membrane potential
TdP: Torsades de pointes ventricular tachycardia
SEM: Standard error of the mean
Vmax: Maximal rate of the action potential upstroke
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Introduction
Ibuprofen is one of the most widely used non-steroidal anti-inflammatory drugs (NSAIDs) 
(Rainsford et al., 2009). However, a recent Danish, nationwide case–time–control study 
(Sondergaard et al., 2017) found that short term therapy with ibuprofen was associated with 
an increased risk of cardiac arrest. It is important to mention that this study also concluded 
that there was an increased risk of out-of-hospital cardiac arrest in diclofenac users. In an 
observational, historical cohort evaluation (Pratt et al., 1994) it was found that the 
ibuprofen cohort had a significantly higher arrhythmic event rate. A case report outlined a 
probable relationship between standard ibuprofen dosing and palpitations (Douglas, 2010). 
Surprisingly, very little is known about the cardiac electrophysiological effect of ibuprofen, 
and the cellular cardiac electrophysiological effects of ibuprofen have been investigated only 
in one study on guinea pig papillary muscle and sinoatrial node (Yang et al., 2008). In these 
preparations ibuprofen dose-dependently shortened action potential duration and decreased 
the maximal rate of depolarization (Vmax) at therapeutically relevant and at high 
concentrations. The effects of ibuprofen on the action potential parameters and the underlying 
transmembrane currents have not yet been reported in other cardiac preparations, including 
those obtained from larger animals (e.g. rabbit or dog), closer to human in heart size, in 
spontaneous frequency, and in basic electrophysiological properties. Repolarization 
prolonging properties have also been reported among fluoroquinolone antibiotic agents 
(Chiba et al., 2000; Garnett & Johannesen, 2016; Komatsu et al., 2019), and combination of 
such antibiotics and NSAIDs is a common practice in the treatment of infections. Therefore, 
the purpose of our work was to further characterize the cellular electrophysiological effects of 
ibuprofen and levofloxacin using preparations obtained from the hearts of large animals, 
namely dogs and rabbits. We found that 50 µM ibuprofen did not influence the action 
potential parameters including action potential duration (APD) in dog and rabbit ventricular 
muscle preparations but at higher concentrations (100-200 µM), especially when 
repolarization reserve (Varró et al., 2000; Roden, 2006; Varró & Baczkó, 2011) had been 
previously attenuated, some repolarization lengthening occurred. Therefore, although at low 
therapeutic concentrations the drug could be considered safe regarding its cardiac 
electrophysiological effects, it is important to further improve our understanding concerning 
the possible unfavorable association between ibuprofen and increased cardiovascular risk 
reported in clinical studies.




All experiments were conducted in compliance with the Guide for the Care and Use of 
Laboratory Animals (USA NIH publication No 85-23, revised 1996) and conformed to 
Directive 2010/63/EU of the European Parliament. The protocols were approved by the 
Review Board of the Department of Animal Health and Food Control of the Ministry of 
Agriculture and Rural Development, Hungary (XIII./1211/2012). Ventricular (papillary) 
muscles were obtained from the right ventricle of rabbits and dogs. Free-running (false 
tendons of) Purkinje fibers were isolated from both ventricles of dog hearts removed through 
a right lateral thoracotomy. Male New Zealand rabbits (2–3 kg) were terminated by rapid 
cervical dislocation, and Beagle dogs (10–15 kg) of both sexes were anesthetized and 
sacrificed using high dose sodium pentobarbital (60 mg/kg iv). The preparations were placed 
in a tissue bath and allowed to equilibrate for at least 2 hours while superfused (flow rate 4-5 
ml/min) with Locke’s solution containing (in mM): NaCl 120, KCl 4, CaCl2 1.8, MgCl2 1, 
NaHCO3 22, and glucose 11. The pH of this solution was 7.35 to 7.40 when gassed with 95% 
O2 and 5% CO2 at 37 °C. During the equilibration period, the ventricular muscle tissues were 
stimulated at a basic cycle length of 1000 ms, Purkinje fibers were stimulated at a basic cycle 
length of 500 ms. Electrical pulses of 0.5–2 ms in duration and twice diastolic threshold in 
intensity (S1) were delivered to the preparations through bipolar platinum electrodes. 
Transmembrane potentials were recorded with the use of glass capillary microelectrodes filled 
with 3 M KCl (tip resistance: 5 to 15 MΩ). The microelectrodes were coupled through an Ag-
AgCl junction to the input of a high-impedance, capacitance-neutralizing amplifier 
(Experimetria 2011). Intracellular recordings were displayed on a storage oscilloscope 
(Hitachi V-555) and led to a computer system (APES) designed for on-line determination of 
the following parameters: resting membrane potential (RMP), action potential amplitude 
(APA), action potential duration at 50% (APD50) and 90% (APD90) repolarization and the 
maximum rate of rise of the action potential upstroke (Vmax). The following types of 
stimulation were applied in the course of the experiments: stimulation with a constant cycle 
length of 1000 ms (ventricular muscles); stimulation with a constant cycle length of 500 ms 
(Purkinje fibers). In case of Purkinje fibers, stimulation with different constant cycle lengths 
ranging from 300 to 1000 ms were also applied. Control recordings were obtained after 
equilibration period. The effects of ibuprofen and DMSO not exceeding 18.8% were 
determined at the given concentrations, after the addition of each compound until 30 minutes 
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elapsed, in a cumulative manner. Compounds were purchased from Sigma/Merck for all 
experiments.
Whole cell configuration of the patch clamp technique
Untreated adult beagle dogs of either sex (body weights 8-15 kg) were used for the study. All 
experiments were conducted in compliance with the Guide for the Care and Use of 
Laboratory Animals (USA NIH publication No 85-23, revised 1985). The protocols were 
approved by the review board of Committee on Animal Research (CAR) of the Albert Szent-
Györgyi Medical University (54/1999 OEj).
The isolation and preparation of dog ventricular myocytes were described earlier in detail 
(Varró et al, 2000). One drop of cell suspension was placed in a transparent recording 
chamber mounted on the stage of an inverted microscope. The myocytes were allowed to 
settle and adhere to the bottom for at least 5-10 minutes before superfusion was initiated with 
Tyrode solution containing (in mM): NaCl 144, NaH2PO4 0.4, KCl 4.0, CaCl2 1.8, MgSO4 
0.53, glucose 5.5 and HEPES 5.0 (pH 7.4, NaOH). Temperature was set to 37°C. Only rod 
shaped cells with clear cross-striations were used. Patch-clamp micropipettes were fabricated 
from borosilicate glass capillaries using a micropipette puller (Flaming/Brown, type P-97, 
Sutter Co., Novato, CA, USA). These electrodes had resistances between 1.5 and 2.5 MΩ. 
Membrane currents were recorded with Axopatch 200B patch-clamp amplifiers (Molecular 
Devices Inc., Sunnyvale, CA, USA) using the whole-cell configuration of the patch-clamp 
technique. After establishing a high resistance (1-10 GΩ) seal by gentle suction, the cell 
membrane beneath the tip of the electrode was disrupted by suction or application of short 
electrical pulses. Membrane currents were digitized after low-pass filtering at 1 kHz using 
analog-to-digital converters (Digidata 1440A, Molecular Devices Inc., Sunnyvale, CA, USA) 
under software control (pClamp 10, Molecular Devices Inc., Sunnyvale, CA, USA). The 
various ion currents were measured as described earlier in detail (Kohajda et al., 2016). The 
same software was used for off-line analysis.
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Statistical analysis
Results are expressed as mean ± S.E.M. Normality of distributions was verified using 
Shapiro-Wilk test, and homogeneity of variances was verified using Bartlett's test in each 
treatment group. Statistical comparisons were made using Student's t-test for Tables 1, 2A, 
and 2B. Variance analysis (ANOVA) for repeated measurements was performed, followed by 
Bonferroni’s post-hoc test for Table 2C. Differences were considered significant when 
p < 0.05.
3. Results
Effects of ibuprofen on transmembrane action potentials
We have investigated the effects of ibuprofen on cardiac action potentials in the concentration 
range of 50–200 µM (10.3–41.2 µg/ml) in rabbit and dog right ventricular papillary muscle 
using the conventional microelectrode technique. As Table 1B and 1C, and Figures 1A and 
2C show, ibuprofen in dog right ventricular papillary muscle at 50 and 200 µM and at 1 Hz 
stimulation frequency did not change the resting membrane potential (RMP), the action 
potential amplitude (APA), or the maximal rate of depolarization (Vmax), but at 200 µM it 
moderately lengthened the action potential duration measured at 50 and 90% levels (APD50 
and APD90). The solvent DMSO at the applied concentration did not affect any of the 
measured action potential parameters (Table 1A and Figures 1E).
In dog Purkinje fibers, action potentials were studied at a 500 ms constant cycle length 
(Table 1D), and also at various stimulation cycle lengths, ranging from 300–1000 ms 
(Figure 2A). At constant cycle length stimulation, ibuprofen at 200 µM concentration elicited 
significant abbreviation of the action potential duration (APD90), while all other 
characteristics, including the RP, APA and Vmax, remained unchanged. As Figure 2B 
indicates, in Purkinje fibers Vmax was decreased and APD was shortened in a frequency 
dependent manner. The decrease in APD90 was more pronounced at slower cycle lengths, 
being significant from 500 ms to 1000 ms. Vmax depression was observed only at high 
stimulation rate corresponding to 300 ms cycle length. DMSO elicited no changes in the 
action potential characteristics of the Purkinje fibers at any cycle length (Table 1A, Figures 
1E, 2C and 2D).
The widely known antibiotic, levofloxacin at 40 µM did not change action potential 
parameters, including APD90 in rabbit papillary muscles at 1 Hz stimulation rate (Table 2B 
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and Figure 3A). However, when levofloxacin was applied in combination with 100 µM 
ibuprofen, the extent of APD lengthening evoked by levofloxacin was greater than that 
observed without the application of ibuprofen (Table 2C and Figure 3B).
In order to elucidate the mechanism of the changes induced by ibuprofen in the action 
potential, the effects of ibuprofen on the transmembrane ionic currents were investigated by 
the whole cell configuration of the patch clamp technique in dog ventricular myocytes at 
250 µM (51.5 µg/ml). The solvent DMSO at the applied concentration did not influence the 
amplitude or kinetics of the measured transmembrane ionic currents (Figures 4–5). In dog 
ventricular myocytes, 250 µM ibuprofen did not significantly alter the inward rectifier (IK1) 
potassium (Figure 4A) and moderately but significantly decreased the transient outward (Ito, 
Figure 4B and 4D) and rapid delayed rectifier (IKr, Figure 4C and 4E) potassium currents.
Since cardiac repolarization is determined not only by outward potassium currents but also by 
late inward sodium (INaL) and L-type inward calcium (ICa) currents, the effect of ibuprofen 
was also studied on INaL and ICa in dog ventricular myocytes. As Figure 5 indicates, 250 µM 
ibuprofen moderately, but in a statistically significant manner decreased the amplitude of both 
INaL and ICa.
4. Discussion
The most important message of the present study is to show that ibuprofen in normal 
situations and therapeutically relevant concentrations exerts none or only moderate 
repolarization lengthening in ventricular muscle preparations, but in a situation where 
repolarization reserve has been attenuated, the degree of repolarization lengthening was 
further increased. This raises the possibility that under such conditions it may enhance 
proarrhythmic risk and consequent sudden cardiac death.
The paucity of reports regarding the cardiac electrophysiological effects of ibuprofen is 
surprising in spite of its worldwide use and the two decades of concerns regarding increased 
risk associated with NSAID drugs in general (Bombardier et al., 2000; Huang, Hsiao, Tsai, et 
al., 2006; Huang, Hsiao, Wen, et al., 2006). In addition, in a recent meta-analysis it has been 
reported that two NSAID drugs, diclofenac and ibuprofen, increase out-of-hospital cardiac 
arrest and consequent sudden deaths (Sondergaard et al., 2017). Although the mechanism of 
these observations is not clear and can be linked to causes other than direct ion channel 
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modulation, the possibility of direct effect of ibuprofen on transmembrane ion channels 
should be also considered. This argument is further strengthened by the previous experimental 
study (Kristóf et al., 2012), which indicated that diclofenac decreased repolarisation reserve 
by inhibiting IKs and IKr in dog heart. In this paper it has also been shown that diclofenac also 
facilitated TdP-like arrhythmia in in vivo rabbit experiments (Kristóf et al., 2012).
The applied concentrations in the present study were similar to those of the work of Yang et 
al. (Yang et al., 2008), and fall into the range of low and high therapeutic plasma levels (10–
50 µg/ml) observed in patients (Holubek et al., 2007). It is also worth mentioning that in 
certain situations, including high age, altered metabolism caused by disease or drug 
interactions, plasma levels may rise beyond normal. In addition, much higher (260 and 
352 µg/ml) plasma levels have also been reported after drug intoxication (Holubek et al., 
2007).
In guinea pig ventricle it has been previously shown (Yang et al., 2008) that ibuprofen in the 
concentration range of 10–80 µg/ml shortened APD and depressed Vmax in a frequency 
dependent manner. In addition, ibuprofen also depressed slow response action potentials and 
sinus nodal frequency both indicative of ICa inhibition (Yang et al., 2008) with concomitant 
increase of PP and QRS intervals in the ECG, but with a shorter QTc (Yang et al., 2008). Our 
present results are in partial agreement with the ones reported by Yang et al. (Yang et al., 
2008). In the present study, we could confirm the frequency-dependent Vmax and ICa inhibition 
reported by Yang et al. (2008), and we also found inhibition of INaL. All these effects would 
lead to shortening in repolarization. However, contrary to the findings reported by Yang et al. 
(2008), in our experiments moderate but statistically significant repolarization lengthening 
was observed in ventricular muscle, but not in Purkinje fibers.  Also, Yarishkin et al. (2009) 
reported that diclofenac but not ibuprofen decreased INaL and ICa in rat ventricular myocytes. 
These dissimilarities are most likely due to the difference in the species (neonatal 
rat vs rabbit), in the experimental conditions (room temperature vs. 37 °C), and in the 
preparations (1 day cultured trabecules vs isolated papillary muscles) used. Unlike rabbit and 
dog, guinea pig ventricle lacks Ito (Zicha et al., 2003), and expresses very strong IKs (Bartos et 
al., 2015). Consequently, in guinea pig ventricle Ito and IKr inhibition have less impact on 
repolarization when compared to that in rabbit or dog. Therefore, in guinea pig ventricle the 
ibuprofen-evoked ICa and INaL inhibition would change the balance of inward and outward 
currents, favoring relative augmentation of outward currents, with an overall result of 
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shortened repolarization. Similar effect should be expected in dog Purkinje fibers, in which 
relatively strong INaL exists. The opposite effect is expected in rabbit and dog ventricle, where 
the density of IKs is weaker than in the guinea pig, therefore IKr should have a stronger 
contribution to repolarization (Jost et al., 2013). In addition, ibuprofen inhibits Ito, which also 
plays an important role in the repolarization reserve (Virág et al., 2011). It should be 
mentioned that NSAIDs, including ibuprofen, are often used in patients with fever. Therefore, 
it would be worthwhile to study the effect of ibuprofen and other NSAIDs under hyperthermic 
conditions as well.
It is well known that fluoroquinolone antibiotics have some repolarization prolonging and 
proarrhythmic potency (Chiba et al., 2000; Garnett & Johannesen, 2016; Komatsu et al., 
2019). To test potential interaction between ibuprofen and these antibiotics, we chose to study 
levofloxacin, which has been reported to possess relatively low proarrhythmic risk (Chiba et 
al., 2000; Milberg et al., 2007), due to its unpronounced repolarization lengthening (Hagiwara 
et al., 2001) and hERG channel inhibiting (Kang et al., 2001) properties compared to others, 
especially sparfloxacin (Chiba et al., 2000; Hagiwara et al., 2001). In our experiments, in 
good agreement with the results of Hagiwara et al., levofloxacin did not evoke significant 
changes when applied alone. However, when levofloxacin was applied in combination with 
ibuprofen, noteworthy APD prolongation was observed. Ibuprofen alone elicited a moderate 
prolongation of APD, and this was increased even further by levofloxacin. It should be 
emphasized that the observed APD prolongation by ibuprofen, with or without levofloxacin, 
is not marked, and it is far from being excessive. Nevertheless, this effect should draw 
attention to the possibility that the combined effect of two drugs with low or even minimal 
effect on repolarization, and seemingly marginal potassium channel blocking properties may 
still be additive by collectively decreasing the repolarization reserve. Therefore, in certain 
situations where repolarization reserve is already attenuated (Varró & Baczkó, 2011), e.g., in 
specific genetic disorders, heart failure, hypertophic cardiomyopathy, low serum potassium 
concentrations or ischemic heart disease, this may lead to marked repolarization defects. This 
may ultimately contribute to enhanced proarrhythmic risk and consequent sudden cardiac 
death.
In conclusion, it seems that ibuprofen in normal situations, at least regarding its cardiac 
electrophysiological properties, is a relatively safe drug. However, in certain conditions 
characterized by attenuated repolarization reserve, ibuprofen may enhance proarrhythmic risk, 
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and may even contribute to the incidence of sudden cardiac death observed in clinical studies. 
This possibility should be considered and taken into account in clinical practice, since 
ibuprofen is a very commonly used over-the-counter drug, taken every day by several million 
people without medical control.
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Figure 1. The effects of ibuprofen and DMSO on action potentials recorded from different 
cardiac preparations. Original action potential records show that ibuprofen (at 100 µM) 
slightly but significantly lengthened the action potential duration in rabbit ventricular muscle 
(panel A) and in dog ventricular muscle (at 200 µM, panel B) at a basic cycle length of 
1000 ms. However, in dog Purkinje fiber (panel C) the drug significantly shortened the action 
potential repolarization at a basic cycle length of 500 ms. DMSO at 2.2‰ did not alter action 
potential duration in any of the preparations at the same cycle lengths (panels D–F).
Figure 2. Cycle length dependent changes in action potential duration (APD90, panels A and 
C) and in maximal rate of depolarization (Vmax, panels B and D) measured under control 
conditions and in the presence of 200 µM ibuprofen and DMSO at 2.2‰ in dog Purkinje fiber 
preparations. Values are means ± SEM, asterisks indicate significant changes.
Figure 3. The effects of levofloxacin alone (panel A) and in combination with 100 µM 
ibuprofen (panel B) on action potentials recorded from rabbit ventricular muscle preparation. 
Original action potential records indicate that 40 µM levofloxacin did not influence the 
ventricular repolarization in rabbit (panel A), however, in combination with 100 µM 
ibuprofen levofloxacin significantly lengthened the action potential duration (panel B).
Figure 4. Panels A–C show the effects of the solvent DMSO at 1‰ and ibuprofen at 250 µM 
on the potassium currents IK1, Ito, and IKr respectively in ventricular myocytes; the insets show 
the applied voltage protocols. Legend: control, black lines and empty boxes; DMSO, green 
lines and green boxes; ibuprofen; red lines and circles. Values are means ± SEM, asterisks 
indicate p<0.05, ANOVA for repeated measurements followed by Bonferroni’s post-hoc test. 
Panels D and E show original current traces of the Ito and IKr currents respectively, recorded in 
control conditions and in the presence of DMSO and after the application of 250 µM 
ibuprofen. In panel E, the dotted arrows indicate the amplitude of IKr tail currents at -40 mV.
Figure 5. Panels A and B show the effects of the solvent DMSO at 1‰ and ibuprofen at 
250 µM on the L-type calcium current (ICa) and the late sodium current (INaL) respectively in 
ventricular myocytes; the insets show the applied voltage protocols. Values are means ± SEM, 
asterisks indicate p<0.05, ANOVA for repeated measurements followed by Bonferroni’s post-
hoc test (A), Student’s t-test (B). Upper panels show original current traces of the INaL and ICa 
currents respectively, recorded in control conditions and in the presence of DMSO and after 
the application of 250 µM ibuprofen. INaL was defined as TTX sensitive current by subtracting 
current traces recorded in the presence of 20 µM TTX from traces of control, DMSO and 
ibuprofen recordings.
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Table 1. The electrophysiological effects of DMSO (2.2‰) and ibuprofen  (50 µM and 200 µM) in canine right ventricular 
papillary muscle preparations (VM; A, B and C), at basic cycle length of 1000 ms; and ibuprofen (200 µM) in canine 
Purkinje fibers (PF; D) at basic cycle length of 500 ms; RP, resting potential; APA, action potential amplitude; Vmax, 
maximum rate of depolarization; APD50 and APD90, action potential durations at 50% and 90% of repolarization. Results 
are expressed as means ± SEM; *p<0.05, Student’s t-test for paired data.
Sample RP APA Vmax APD50 APD90 APD90
A
(mV) (mV) (V/s) (ms) (ms) (%)
Control Canine VM -83.3 106.7 136.7 157.8 203.6
(6) ± 2.3 ± 1.5 ± 14.2 ± 11.6 ± 7.6
DMSO Canine VM -85.8 105.3 123.3 153.8 201.6 -1.0
(2.2‰) (6) ± 1.7 ± 1.4 ± 17.0 ± 11.5 ± 8.0 ± 1.2
Sample RP APA Vmax APD50 APD90 APD90
B
(mV) (mV) (V/s) (ms) (ms) (%)
Control Canine VM -83.2 108.1 175.2 187.0 227.5
(8) ± 1.6 ± 1.0 ± 22.3 ± 9.3 ± 9.7
Ibuprofen Canine VM -85.3 106.7 172.4 187.7 225.9 -0.6
 (50 µM) (8) ± 2.1 ± 1.9 ± 29.9 ± 9.7 ± 8.9 ± 1.0
Sample RP APA Vmax APD50 APD90 APD90
C
(mV) (mV) (V/s) (ms) (ms) (%)
Control Canine VM -89.0 110.6 174.6 173.8 214.1
(6) ± 1.8 ± 2.4 ± 20.3 ± 8 ± 5.9
Ibuprofen Canine VM -89.1 113.4 192.9 181.6 223.0 4.3
 (200 µM) (6) ± 3.2 ± 3.0 ± 27.1 ± 6.3 ± 4.9* ± 1.0
Sample RP APA Vmax APD50 APD90 APD90
D
(mV) (mV) (V/s) (ms) (ms) (%)
Control Canine PF -89.7 133.5 580.7 163.9 253.4
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(7) ± 0.7 ± 3.3 ± 36.0 ± 10.9 ± 14.2
Ibuprofen Canine PF -87.3 135.9 621.5 163.7 242.0 -4.5
 (200 µM) (7) ± 1.0 ± 3.4 ± 93.5 ± 11.2 ± 13.7* ± 0.7
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Table 2. The electrophysiological effects of DMSO (2.2‰), levofloxacin (40 µM) and ibuprofen (100 µM) in rabbit right 
ventricular papillary muscle preparations at a basic cycle length of 1000 ms; APA, action potential amplitude; Vmax, 
maximum rate of depolarization; APD50 and APD90, action potential durations at 50% and 90% of repolarization. Results 
are expressed as means ± SEM; *p<0.05, Student’s t-test for paired data (Tables 2A and 2B), ANOVA for repeated 
measurements followed by Bonferroni’s post-hoc test (Table 2C).
Sample RP APA Vmax APD50 APD90 APD90
A
(mV) (mV) (V/s) (ms) (ms) (%)
Control Rabbit VM -81.7 119.1 222.0 123.8 158.7
(6) ± 1.9 ± 2.3 ± 21.9 ± 7.9 ± 7.7
DMSO Rabbit VM -81.6 115.8 181.9 123.0 159.3 0.7
(2.2‰) (6) ± 2.6 ± 4.7 ± 20.5 ± 7.2 ± 7.1 ± 1.9
Sample RP APA Vmax APD50 APD90 APD90
B
(mV) (mV) (V/s) (ms) (ms) (%)
Control Rabbit VM -86.9 109.0 127.6 149.6 163.8
(7) ± 1.3 ± 2.6 ± 7.5 ± 9.6 ± 6.6
Levofloxacin Rabbit VM -85.8 111.3 128.0 156.9 164.1 0.1
 (40 µM) (7) ± 2.0 ± 4.0 ± 8.0 ± 26.0 ± 7.0 ± 0.8
Sample RP APA Vmax APD50 APD90 APD90
C
(mV) (mV) (V/s) (ms) (ms) (%)
Control Rabbit VM -86.5 108.0 147.7 121.8 164.7
(9) ± 1.6 ± 3.7 ± 21.2 ± 7.1 ± 8.7
Ibuprofen Rabbit VM -85.6 107.3 145.2 123.3 169.3 2.9
(100 µM) (9) ± 2.7 ± 2.3 ± 19.3 ± 7.5 ± 8.7* ± 0.9
Levofloxacin Rabbit VM 87.4 111.0 148.5 138.2 183.2 7.6
(40 µM) (9) ± 2.2 ± 3.7 ± 19.4 ± 13.1 ± 12.5* ± 1.9
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Figure 1. The effects of ibuprofen and DMSO on action potentials recorded from different cardiac 
preparations. Original action potential records show that ibuprofen (at 100 µM) slightly but significantly 
lengthened the action potential duration in rabbit ventricular muscle (panel A) and in dog ventricular muscle 
(at 200 µM, panel C) at a basic cycle length of 1000 ms. However, in dog Purkinje fiber (panel B) the drug 
significantly shortened the action potential repolarization at a basic cycle length of 500 ms. DMSO at 2.2‰ 
did not alter action potential duration in any of the preparations at the same cycle lengths (panels D–F). 
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Figure 2. Cycle length dependent changes in action potential duration (APD90, panels A and C) and in 
maximal rate of depolarization (Vmax, panels B and D) measured under control conditions and in the 
presence of 200 µM ibuprofen and DMSO at 2.2‰ in dog Purkinje fiber preparations. Values are means ± 
SEM, asterisks indicate significant changes. 
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Figure 3. The effects of levofloxacin alone (panel A) and in combination with 100 µM ibuprofen (panel B) on 
action potentials recorded from rabbit ventricular muscle preparation. Original action potential records 
indicate that 40 µM levofloxacin did not influence the ventricular repolarization in rabbit (panel A), however, 
in combination with 100 µM ibuprofen levofloxacin significantly lengthened the action potential duration 
(panel B). 
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Figure 4. Panels A–C show the effects of the solvent DMSO at 1‰ and ibuprofen at 250 µM on the 
potassium currents IK1, Ito, and IKr respectively in ventricular myocytes; the insets show the applied 
voltage protocols. Legend: control, black lines and empty boxes; DMSO, green lines and green boxes; 
ibuprofen; red lines and circles. Values are means ± SEM, asterisks indicate p<0.05, ANOVA for repeated 
measurements followed by Bonferroni’s post-hoc test. Panels D and E show original current traces of the Ito 
and IKr currents respectively, recorded in control conditions and in the presence of DMSO and after the 
application of 250 µM ibuprofen. In panel E, the dotted arrows indicate the amplitude of IKr tail currents at -
40 mV. 
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Figure 5. Panels A and B show the effects of the solvent DMSO at 1‰ and ibuprofen at 250 µM on the L-
type calcium current (ICa) and the late sodium current (INaL) respectively in ventricular myocytes; the 
insets show the applied voltage protocols. Values are means ± SEM, asterisks indicate p<0.05, ANOVA for 
repeated measurements followed by Bonferroni’s post-hoc test (A), Student’s t-test (B). Upper panels show 
original current traces of the INaL and ICa currents respectively, recorded in control conditions and in the 
presence of DMSO and after the application of 250 µM ibuprofen. INaL was defined as TTX sensitive current 
by subtracting current traces recorded in the presence of 20 µM TTX from traces of control, DMSO and 
ibuprofen recordings. 
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